We are currently seeking a Student Assistant* to support our Clinical Trial Logistics team within our Global Patient Supply department. You will work in Munich (Germany) in an interdisciplinary environment with colleagues from Germany and the US (Houston, TX).
Your main responsibilities will include but are not limited to the following tasks:
- Support the Clinical Supply Chain Management/ Logistics
- Auxiliary Medicinal Product (AxMP)
- TCER® IMP
- Clinical trial material
- Clinical trial equipment
- Support the management of TMF related activities
- Review and manage clinical trial documents to ensure formal compliance
- Assist with internal projects, according to the Project Lead’s supervision
- Support diverse clinical trial logistics tasks
We are a committed and inspired team and cherish the collegial, highly motivated and family-friendly atmosphere within Immatics. As a Student Assistant*, you can work flexible hours, which makes it easy to combine your work at Immatics with your studies. In addition, we offer you the opportunity to gain practical experience and to establish valuable contacts for your future career. With us, you will gain an insight into the working methods and requirements of a growing biotech company in a dynamic working environment.
*We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.
This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.